Yunn-Hwa Ma

Title: Yunn-Hwa Ma: Innovator in Coagulation Factor XIII Research

Introduction: Yunn-Hwa Ma is an accomplished inventor based in Taoyuan, Taiwan, whose groundbreaking work has led to significant advancements in the field of coagulation research. With a focus on developing innovative solutions, Ma has garnered attention within the scientific community.

Latest Patents: Ma holds a patent for "Aptamers for targeting coagulation factor XIII and uses thereof." This patent describes an aptamer that is specifically designed to target coagulation factor XIII (FXIII). The aptamer serves as a bio-tool capable of labeling thrombi and acts as a targeting molecule for drug delivery to thrombotic areas. The implications of this invention extend to methods for treating diseases associated with FXIII, such as thrombosis.

Career Highlights: Yunn-Hwa Ma is associated with Chang Gung University, where he has contributed to various research initiatives. His innovative approach to understanding coagulation has positioned him as a key figure in the development of therapies for thrombotic conditions.

Collaborations: Throughout his career, Ma has collaborated with esteemed colleagues, including Ching-Ping Tseng and Kai-Wen Cheng. These collaborations have further enriched his research endeavors and fostered a collaborative environment that encourages innovation.

Conclusion: Yunn-Hwa Ma's contributions to the field of coagulation research exemplify his commitment to innovation and improvement in medical therapies. His work not only holds promise for enhancing drug delivery mechanisms but also offers potential solutions for addressing serious health conditions associated with thrombus formation.